Morgan Stanley analyst Dara Mohsenian lowered the firm’s price target on Zevia (ZVIA) to $1.75 from $2.90 and keeps an Equal Weight rating on the shares. Q4 results were mixed, with a sales miss and adjusted EBITDA beat, while the company gave below-consensus initial FY26 guidance, the analyst noted.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVIA:
- Zevia price target lowered to $3 from $3.50 at Goldman Sachs
- Zevia: Mixed Quarter, Cost Headwinds, and Strategy Refocus Support Balanced Risk-Reward and Hold Rating
- Zevia reports Q4 EPS (2c), consensus (3c)
- Zevia sees Q1 revenue $40M-$42M, consensus $40.5M
- Zevia sees FY26 revenue $169M-$173M, consensus $173.8M